Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and ...
The agency’s road map, which outlines goals for promoting safe and equitable adoption, comes as the future of AI policy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback